434 related articles for article (PubMed ID: 21684000)
1. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
[TBL] [Abstract][Full Text] [Related]
2. Anionic surfactant templated mesoporous silicas (AMSs).
Han L; Che S
Chem Soc Rev; 2013 May; 42(9):3740-52. PubMed ID: 23081758
[TBL] [Abstract][Full Text] [Related]
3. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
[TBL] [Abstract][Full Text] [Related]
5. Facile incorporation of aggregation-induced emission materials into mesoporous silica nanoparticles for intracellular imaging and cancer therapy.
Zhang X; Zhang X; Wang S; Liu M; Zhang Y; Tao L; Wei Y
ACS Appl Mater Interfaces; 2013 Mar; 5(6):1943-7. PubMed ID: 23363527
[TBL] [Abstract][Full Text] [Related]
6. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
7. Anionic-cationic switchable amphoteric monodisperse mesoporous silica nanoparticles.
Ma Y; Xing L; Zheng H; Che S
Langmuir; 2011 Jan; 27(2):517-20. PubMed ID: 21166445
[TBL] [Abstract][Full Text] [Related]
8. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
9. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
Roggers RA; Lin VS; Trewyn BG
Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
[TBL] [Abstract][Full Text] [Related]
10. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding.
Wang LS; Wu LC; Lu SY; Chang LL; Teng IT; Yang CM; Ho JA
ACS Nano; 2010 Aug; 4(8):4371-9. PubMed ID: 20731423
[TBL] [Abstract][Full Text] [Related]
11. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
Paula AJ; Araujo Júnior RT; Martinez DS; Paredes-Gamero EJ; Nader HB; Durán N; Justo GZ; Alves OL
ACS Appl Mater Interfaces; 2013 Sep; 5(17):8387-93. PubMed ID: 23841723
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
13. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
[TBL] [Abstract][Full Text] [Related]
14. A novel anionic surfactant templating route for synthesizing mesoporous silica with unique structure.
Che S; Garcia-Bennett AE; Yokoi T; Sakamoto K; Kunieda H; Terasaki O; Tatsumi T
Nat Mater; 2003 Dec; 2(12):801-5. PubMed ID: 14634644
[TBL] [Abstract][Full Text] [Related]
15. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles.
He Q; Shi J; Chen F; Zhu M; Zhang L
Biomaterials; 2010 Apr; 31(12):3335-46. PubMed ID: 20106517
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
[TBL] [Abstract][Full Text] [Related]
18. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
19. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy.
Zhu J; Wang H; Liao L; Zhao L; Zhou L; Yu M; Wang Y; Liu B; Yu C
Chem Asian J; 2011 Sep; 6(9):2332-8. PubMed ID: 21744503
[TBL] [Abstract][Full Text] [Related]
20. Polymer-mesoporous silica materials templated with an oppositely charged surfactant/polymer system for drug delivery.
Lin H; Zhu G; Xing J; Gao B; Qiu S
Langmuir; 2009 Sep; 25(17):10159-64. PubMed ID: 19552374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
